Open access
Jul 2026
Relative importance of blood-based biomarkers for Alzheimer’s disease-specific neurodegeneration and cognitive decline
A stratified approach based on amyloid status is essential for the optimal application of blood-based biomarkers in monitoring disease progression and evaluating therapeutic efficacy in future clinical trials and precision medicine.
Keun You Kim, Hyunsun Ham, E. Yoon et al.
· The journal of prevention of... · 0 citations